期刊文献+

HPLC-Q-TOF-MS分析注射用泮托拉唑钠中降解杂质 被引量:1

Analysis of Degradation Impurities in Pantoprazole Sodium for Injection by HPLC-Q-TOF-MS
原文传递
导出
摘要 目的优化注射用泮托拉唑钠有关物质检查方法,并用高效液相色谱-四级杆飞行时间质谱法(HPLC-QTOF-MS)对注射用泮托拉唑钠中降解杂质进行结构鉴定。方法采用色谱柱Waters Symmetry C18(250 mm×4.6 mm,5μm);流动相:10 mmol·L^(-1)乙酸铵(用乙酸调节p H至4.5)(A)-乙腈(B),梯度洗脱(0~20 min,B相20%;20~30 min,B相20%→40%;30~45 min,B相40%→30%;45.01~65 min,B相20%);流速:1.0 m L·min^(-1);检测波长:289 nm;进样量:20μL;柱温:35℃;离子源:ESI源;扫描模式:正离子模式。结果优化后有关物质测定方法可有效分离各降解杂质。根据各降解杂质的二级质谱图以及高分辨数据,推测出了4个降解杂质的结构式。结论所建立的色谱条件可有效检测注射用泮托拉唑钠中的有关物质,降解杂质结构式的确定为该产品稳定性研究提供了技术支持。 OBJECTIVE To improve the method for the examination of related substances in pantoprazole sodium for injection and establish an HPLC-Q-TOF-MS method for the structure determination of the degradation impurities. METHODS The analysis was performed on Waters Symmetry C18(250 mm×4.6 mm, 5 μm) with the mobile phase consisting of 10 mmol·L^-1 ammonium acetate(adjusted to pH 4.5 by acetic acid)-acetonitrile in gradient mode. The detection wavelength was 289 nm and the flow rate was 1.0 mL·min^-1 The compound was ionized in the electrospray ionization(ESI) and operated in positive mode. RESULTS The improved method for the examination of related substances could separate the major degradation impurities effectively. According to the mass spectrum and high resolution data of degradation impurities in pantoprazole sodiu the structure of four degration impurities could be infered. CONCLUSION The chromatographic condition can detect the related substances in pantoprazole sodium for injection effectively. And the structure identification of the degradation impurities can provide technical support for stability study of this medicine.
出处 《中国现代应用药学》 CAS CSCD 2016年第9期1174-1177,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 泮托拉唑钠 杂质 高效液相色谱-四级杆飞行时间质谱法 鉴定 pantoprazole sodium impurities HPLC-QTOF-MS determination
  • 相关文献

参考文献6

二级参考文献7

  • 1Kumar YR, Babur JM, Sarma MSP,et al. Structural identification and characterization of impurities in moxifloxacin. Pharm Biomed Anal, 2004,34(5) :1125.
  • 2Lee MS, Kems EH. LC/MS applications in drug development. Mass Spectrom Rev,1999,18(3 -4) :187.
  • 3Santiago TM, Lopez LM. Nitrendipine: a new dihydropyridine calcium - channel antagonist for the treatment of hypertension. Ann Pharrnacother, 1990,24 ( 2 ) : 167.
  • 4BP. 2010. Vol Ⅱ :1515.
  • 5刘小平.尼群地平的合成[J].湘潭大学自然科学学报,1998,20(2):77-78. 被引量:6
  • 6黄朝瑜,蔡美明,樊夏雷.HPLC-MS/MS测定达卡巴嗪有关物质[J].药物分析杂志,2010,30(5):879-882. 被引量:3
  • 7马超,周颖,童元峰,吴松,张启明,王琰.HPLC/DAD/MS法测定氯雷他定及其微量杂质[J].药物分析杂志,2010,30(11):2007-2011. 被引量:5

共引文献21

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部